NCT05908838 - Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 1, 2022

Study Completion Date

December 2, 2022

Conditions

Gastric Cancer (Diagnosis)

Interventions

DRUG

Modified Banxia Xiexin Decoction

The treatment group#Modified Banxia Xiexin Decoction group#was given Modified Banxia Xiexin Decoction, 2 bags each time, 2 times a day, and 1 hour after meals. The control group(chemotherapy group)#Chemotherapy regimen was based on the Chinese Clinical Oncology Association Guidelines for the Diagnosis and Treatment of Gastric Cancer (2018), including oxaliplatin +5-FU/CF, SOX regimen, XELOX regimen, and S-1 monotherapy regimen.

DRUG

combination chemotherapy with Placebo granules

All Listed Sponsors

lead

ShuGuang Hospital

OTHER